As an important step toward overcoming the technical and environmental limitations of current REE processing methods, the LLNL team has patented and demonstrated a biobased, all-aqueous REE extraction and separation scheme using the REE-selective lanmodulin protein. Lanmodulin can be fixed onto porous support materials using thiol-maleimide chemistry, which can enable tandem REE purification…
Keywords
- Show all (120)
- Instrumentation (38)
- Sensors (15)
- Diagnostics (13)
- Electric Grid (8)
- Carbon Utilization (6)
- Brain Computer Interface (BCI) (4)
- Ground Penetrating Radar (4)
- Materials for Energy Products (4)
- Defense Technologies (3)
- 3D Printing (2)
- Additive Manufacturing (2)
- Direct Air Capture (2)
- National Security Forensics (2)
- Power Electronics (2)
- Rare Earth Elements (REEs) (2)
- Spectrometers (2)
- Inertial Fusion Energy (IFE) (1)
- (-) Therapeutics (5)
- (-) Synthesis and Processing (3)
- (-) Vaccines (2)
LLNL researchers have developed a Li-Sn-Zn ternary alloy and its method of production. Instead of traditional alloying techniques, the alloy was synthesized using mechanical alloying (high energy ball milling). With high purity elemental powders of lithium, tin and zinc, LLNL researchers were able to prepare Li60Sn20Zn20 as well as Li70Sn20Zn10 nanopowders.
CMI—a DOE Energy Innovation Hub—is a public/private partnership led by the Ames Laboratory that brings together the best and brightest research minds from universities, national laboratories (including LLNL), and the private sector to find innovative technology solutions to make better use of materials critical to the success of clean energy technologies as well as develop resilient and secure…
To address shortcomings of current liposome drug delivery systems, the patented innovation uses drug-loaded liposomes containing carbon nanotube porins (CNTPs) inserted into the liposomal membranes for the delivery of the encapsulated drugs. Short CNTPs (10 nm in length) with narrow diameter (0.8 nm) has been demonstrated to facilitate efficient fusion of lipid bilayers resulting in the…
A new approach of developing synthetic antibacterial mineral assemblages can be used as an alternative treatment when traditional antibiotics fail in clinical and agricultural settings. Mineral mixtures can be synthesized with tunable metal release and reactive oxygen species generation that are capable of killing human pathogens and promoting wound healing. One of the key components in the…
The method described in a pending patent application uses a novel thiacrown (dibenzohexathia-18-crown-6) for efficient extraction of 197m,gHg and 197gHg from irradiated Pt target foils. The separation of 197m,gHg and 197gHg from Pt foils using this novel thiacrown was found to be highly specific. No detectable amount of the Pt foil was seen in the…
Combining the principles of nanotechnology, cell-free protein synthesis and microfluidics, LLNL researchers have developed a reusable, portable programmable system that can create purified, concentrated protein product in vitro in a microfluidic device containing nucleic acids.
LLNL’s high throughput method involves proteome-wide screening for linear B-cell epitopes using native proteomes isolated from a pathogen of interest and convalescent sera from immunized animals. LLNL researchers have applied their newly developed generalizable screening method to the identification of pathogenic bacteria by screening linear B-cell epitopes in the proteome of Francisella…
LLNL scientists developed novel hydrogels, which are biodegradable soft materials synthesized by a water-soluble polymer. Incorporating silver imparts antimicrobial activity to the material at low concentration compared to currently used silver nanoparticles. Our hydrogels are composed of silver ions instead of silver nanoparticles, which eliminates the toxicity concerns of modern silver…
LLNL has developed a novel process of production, isolation, characterization, and functional re-constitution of membrane-associated proteins in a single step. In addition, LLNL has developed a colorimetric assay that indicates production, correct folding, and incorporation of bR into soluble nanolipoprotein particles (NLPs).
LLNL has developed an approach, for formation of NLP/…